<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1273408</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1273408</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Mechanistic insight of <italic>Staphylococcus aureus</italic> associated skin cancer in humans by <italic>Santalum album</italic> derived phytochemicals: an extensive computational and experimental approaches</article-title>
<alt-title alt-title-type="left-running-head">Hosen et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1273408">10.3389/fchem.2023.1273408</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hosen</surname>
<given-names>Md. Eram</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2313326/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jahan Supti</surname>
<given-names>Sumaiya</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Akash</surname>
<given-names>Shopnil</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1833092/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rahman</surname>
<given-names>Md. Ekhtiar</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Faruqe</surname>
<given-names>Md Omar</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2282365/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manirujjaman</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acharjee</surname>
<given-names>Uzzal Kumar</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaafar</surname>
<given-names>Abdel-Rhman Z.</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1866827/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ouahmane</surname>
<given-names>Lahcen</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1719075/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sitotaw</surname>
<given-names>Baye</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2375423/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bourhia</surname>
<given-names>Mohammed</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/915935/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zaman</surname>
<given-names>Rashed</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/337917/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Professor Joarder DNA and Chromosome Research Laboratory</institution>, <institution>Department of Genetic Engineering and Biotechnology</institution>, <institution>University of Rajshahi</institution>, <addr-line>Rajshahi</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Genetic Engineering and Biotechnology</institution>, <institution>University of Rajshahi</institution>, <addr-line>Rajshahi</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pharmacy</institution>, <institution>Faculty of Allied Health Sciences</institution>, <institution>Daffodil International University</institution>, <addr-line>Dhaka</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Computer Science and Engineering</institution>, <institution>University of Rajshahi</institution>, <addr-line>Rajshahi</addr-line>, <country>Bangladesh</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Structural and Cellular Biology</institution>, <institution>Tulane University School of Medicine</institution>, <addr-line>New Orleans</addr-line>, <addr-line>LA</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Genetics</institution>, <institution>University of Alabama</institution>, <addr-line>Birmingham</addr-line>, <addr-line>AL</addr-line>, <country>United States</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Botany and Microbiology</institution>, <institution>College of Science</institution>, <institution>King Saud University</institution>, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Laboratory of Microbial Biotechnologies, Agrosciences and Environment (BioMAgE)</institution>, <institution>Labeled Research Unit-CNRSTN&#xb0;4</institution>, <institution>Cadi Ayyad University</institution>, <addr-line>Marrakesh</addr-line>, <country>Morocco</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Department of Biology</institution>, <institution>Bahir Dar University</institution>, <addr-line>Bahir Dar</addr-line>, <country>Ethiopia</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>Department of Chemistry and Biochemistry</institution>, <institution>Faculty of Medicine and Pharmacy</institution>, <institution>Ibn Zohr University</institution>, <addr-line>Laayoune</addr-line>, <country>Morocco</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/387261/overview">Khurshid Ahmad</ext-link>, Yeungnam University, Republic of Korea</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/491029/overview">Manikanta Murahari</ext-link>, K. L. University, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1053876/overview">Bilal Shaker</ext-link>, Ewha Womans University, Republic of Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1217954/overview">Khaled Mohamed Darwish</ext-link>, Suez Canal University, Egypt</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Rashed Zaman, <email>rashedzaman@ru.ac.bd</email>; Baye Sitotaw, <email>mershabaye@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>11</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1273408</elocation-id>
<history>
<date date-type="received">
<day>06</day>
<month>08</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Hosen, Jahan Supti, Akash, Rahman, Faruqe, Manirujjaman, Acharjee, Gaafar, Ouahmane, Sitotaw, Bourhia and Zaman.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hosen, Jahan Supti, Akash, Rahman, Faruqe, Manirujjaman, Acharjee, Gaafar, Ouahmane, Sitotaw, Bourhia and Zaman</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>An excessive amount of multidrug-resistant <italic>Staphylococcus aureus</italic> is commonly associated with actinic keratosis (AK) and squamous cell carcinoma (SCC) by secreted virulence products that induced the chronic inflammation leading to skin cancer which is regulated by staphylococcal accessory regulator (SarA). It is worth noting that there is currently no existing published study that reports on the inhibitory activity of phytochemicals derived from <italic>Santalum album</italic> on the SarA protein through <italic>in silico</italic> approach. Therefore, our study has been designed to find the potential inhibitors of <italic>S. aureu</italic>s SarA protein from <italic>S. album</italic>-derived phytochemicals. The molecular docking study was performed targeting the SarA protein of <italic>S. aureus</italic>, and CID:5280441, CID:162350, and CID: 5281675 compounds showed the highest binding energy with &#x2212;9.4&#xa0;kcal/mol, &#x2212;9.0&#xa0;kcal/mol, and &#x2212;8.6&#xa0;kcal/mol respectively. Further, molecular dynamics simulation revealed that the docked complexes were relatively stable during the 100&#xa0;ns simulation period whereas the MMPBSA binding free energy proposed that the ligands were sustained with their binding site. All three complexes were found to be similar in distribution with the apoprotein through PCA analysis indicating conformational stability throughout the MD simulation. Moreover, all three compounds&#x2019; ADMET profiles revealed positive results, and the AMES test did not show any toxicity whereas the pharmacophore study also indicates a closer match between the pharmacophore model and the compounds. After comprehensive <italic>in silico</italic> studies we evolved three best compounds, namely, Vitexin, Isovitexin, and Orientin, which were conducted <italic>in vitro</italic> assay for further confirmation of their inhibitory activity and results exhibited all of these compounds showed strong inhibitory activity against <italic>S. aureus.</italic> The overall result suggests that these compounds could be used as a natural lead to inhibit the pathogenesis of <italic>S. aureus</italic> and antibiotic therapy for <italic>S. aureus</italic>-associated skin cancer in humans as well.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig>
<graphic xlink:href="FCHEM_fchem-2023-1273408_wc_abs.tif"/>
</fig>
</p>
</abstract>
<kwd-group>
<kwd>skin cancer</kwd>
<kwd>
<italic>Staphylococcus aureus</italic>
</kwd>
<kwd>staphylococcal accessory regulator (SarA)</kwd>
<kwd>
<italic>Santalum album</italic>
</kwd>
<kwd>molecular docking</kwd>
<kwd>molecular dynamics</kwd>
<kwd>ADMET prediction</kwd>
<kwd>antibacterial activity</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Medicinal and Pharmaceutical Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>1 Introduction</title>
<p>Skin, the largest organ of the human body, is vulnerable to various diseases, with skin cancer being a significant concern (<xref ref-type="bibr" rid="B71">Zhang et al., 2020</xref>). Actinic keratosis (AK), a premalignant lesion, can lead to the development of squamous cell carcinoma (SCC), a common type of skin cancer (<xref ref-type="bibr" rid="B38">Krueger et al., 2022b</xref>). Chronic inflammation plays a crucial role in the progression from AK to SCC, particularly in individuals with inflammatory skin disorders. SCC tends to develop in areas of the skin that are chronically inflamed, such as burns, wounds, and ulcers (<xref ref-type="bibr" rid="B14">Ci&#x105;&#x17c;y&#x144;ska et al., 2021</xref>). The chronic inflammation associated with skin cancer is often driven by the synthesis of reactive oxygen species (ROS), leading to DNA damage and genomic instability (<xref ref-type="bibr" rid="B12">Chakraborty et al., 2020</xref>). The skin is inhabited by various microorganisms, including bacteria, fungi, archaea, and viruses, collectively known as the skin microbiome. The microbiome has been found to influence skin inflammation. Certain microbes, such as <italic>Staphylococcus aureus</italic>, <italic>Helicobacter pylori</italic>, <italic>Salmonella typhi</italic>, <italic>Escherichia coli</italic>, and human <italic>papillomavirus</italic>, possess carcinogenic potential. These microorganisms secrete products that induce oxidative stress and DNA damage, contributing to skin cancer development (<xref ref-type="bibr" rid="B11">Byrd Allyson et al., 2018</xref>; <xref ref-type="bibr" rid="B45">Okunade, 2020</xref>; <xref ref-type="bibr" rid="B37">Krueger et al., 2022a</xref>).</p>
<p>
<italic>S. aureus</italic> is a highly detrimental human pathogenic bacterium and a leading cause of healthcare-associated infections. It is estimated that <italic>S. aureus</italic> colonizes approximately 30% of the human population (<xref ref-type="bibr" rid="B46">Oliveira et al., 2022</xref>). According to the CDC, in 2011, there were 80,461 reported cases and 11,285 fatalities in the United States due to invasive <italic>S. aureus</italic> infections (<xref ref-type="bibr" rid="B51">Reimche et al., 2021</xref>). This gram-positive bacterium is commonly found on the skin and mucous membranes, and it is responsible for a wide range of infections, including bacteremia, infective endocarditis, skin and soft tissue infections, osteomyelitis, septic arthritis, pulmonary infections, gastroenteritis, meningitis and urinary tract infections (<xref ref-type="bibr" rid="B57">Taylor and Unakal, 2022</xref>). An excessive presence of multidrug-resistant <italic>S. aureus</italic> is often associated with the development of skin cancer. The colonization of <italic>S. aureus</italic> on precancerous skin and the secretion of virulence products contribute to the progression of skin cancer (<xref ref-type="bibr" rid="B40">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="B42">Madhusudhan et al., 2020</xref>; <xref ref-type="bibr" rid="B38">Krueger et al., 2022b</xref>).</p>
<p>The occurrence of this widespread infection can be attributed to the remarkable diversity of extracellular and cell wall-associated virulence factors that are expressed in a coordinated manner during the infectious process (<xref ref-type="bibr" rid="B67">Wang et al., 2022</xref>). Many of these virulence components manifest as either secreted proteins or cell surface-associated proteins. Secreted proteins such as hemolysins, lipases, and proteolytic enzymes are responsible for invasion and tissue damage. On the other hand, adhesion to host tissues is mediated by cell surface-associated proteins, such as protein A and proteins that bind to fibronectin (<xref ref-type="bibr" rid="B21">El-Ganiny et al., 2022</xref>). The expression of these virulence factors is regulated by a key protein called staphylococcal accessory regulator (SarA), which plays a pivotal role in <italic>S. aureus</italic> pathogenesis (<xref ref-type="bibr" rid="B65">Wang et al., 2019</xref>). Upon certin damage in skin <italic>S. aureus</italic> get opportunity to infect where the staphylococcal accessory regulator (SarA) protein regulate the secretion of virulence factor which leads to the development of squamous cell carcinoma in that infection region (<xref ref-type="fig" rid="F1">Figure 1</xref>). These virulence proteins induce chronic inflammation, which can lead to the development of skin cancer. SarA, a 124-residue (14.7-kDa) protein, binds to the promoter region of target genes and serves as a promising target for the development of antibiotic cancer therapy against <italic>S. aureus</italic>-associated skin cancer (<xref ref-type="bibr" rid="B20">D&#xed;az et al., 2022</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Schematic representation of the development of <italic>S. aureus</italic> associated skin cancer.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g001.tif"/>
</fig>
<p>The primary approach for treating <italic>S. aureus</italic> infections is the administration of antibiotic drugs from the <italic>&#x3b2;</italic>-lactam class, such as cephalosporins, oxacillin, or nafcillin (<xref ref-type="bibr" rid="B8">Blackman et al., 2020</xref>). However, in recent years, there has been increasing resistance of <italic>S. aureus</italic> to various antibiotic drugs, including methicillin, nafcillin, oxacillin, vancomycin, penicillin, cotrimoxazole, amoxicillin, tetracycline and cloxacillin (<xref ref-type="bibr" rid="B52">Shariati et al., 2020</xref>; <xref ref-type="bibr" rid="B51">Reimche et al., 2021</xref>). Although synthetic drugs remain the primary means of controlling these infections, they often come with significant side effects. Hence, there is a pressing need to explore alternative medicines that can effectively treat these bacteria while minimizing adverse effects. Therefore, SarA protein setected as a promising drug target to development of antibacterial drug for skin cancer associated bacteria <italic>S. aureus.</italic>
</p>
<p>
<italic>S. album</italic>, commonly known as sandalwood and belonging to the family Santalaceae, is a medicinal plant known for its rich phytochemical content and traditional use in treating a wide range of human diseases (<xref ref-type="bibr" rid="B3">Akbar and Akbar, 2020</xref>). In addition to its medicinal applications, sandalwood is also utilized in cosmetic products. The leaf extract of <italic>S. album</italic> exhibits diverse biological properties, including antimicrobial, antioxidant, and cytotoxic effects (<xref ref-type="bibr" rid="B50">Pullaiah et al., 2021</xref>). The leaves of this plant species are particularly abundant in alkaloids, flavonoids, terpenoids, tannins, phenolics, saponins, and steroids (<xref ref-type="bibr" rid="B23">Ghildiyal et al., 2020</xref>). These compounds contribute to the antimicrobial activity of <italic>S. album</italic>, making it a potential source for improving the development of antibacterial drugs.</p>
<p>This research aims to identify promising lead compounds that could inhibit the pathogenesis of <italic>S. aureus</italic> and serve as a potential therapy for <italic>S. aureus</italic>-associated skin cancer in humans.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Material and methods</title>
<sec id="s2-1">
<title>2.1 Collection and preparation of <italic>S. album</italic> phytochemicals</title>
<p>After a comprehensive literature review, 50 chemical compounds of <italic>S. album</italic> (<xref ref-type="bibr" rid="B41">Liu et al., 2008</xref>; <xref ref-type="bibr" rid="B63">Umdale et al., 2020</xref>) were retrieved in sdf format from the Pub-Chem database (<xref ref-type="bibr" rid="B33">Kim et al., 2021</xref>). The compounds were then cleaned, and energy was minimized using Avogadro software v1.2.0 with the help of mmf94 force field (<xref ref-type="bibr" rid="B26">Hanwell et al., 2012</xref>). The scaffold structure of the hit compounds shown in <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Scafold structure of three best compounds.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g002.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>2.2 Protein preparation</title>
<p>The x-ray crystallography structure of SarA protein of <italic>S. aureus</italic> (PDB ID: 2FNP) was retrieved from the protein data bank (<xref ref-type="bibr" rid="B9">Bouley et al., 2015</xref>)<bold>.</bold> With the aid of the software Discovery Studio v21.1.0.0 (<ext-link ext-link-type="uri" xlink:href="https://discover.3ds.com/discovery-studio-visualizer-download">https://discover.3ds.com/discovery-studio-visualizer-download</ext-link>), the protein structure was initially cleaned and heteroatoms were removed. Then, using the GROMOS96 43b1 force field and the SwissPDB Viewer software v4.1 (<ext-link ext-link-type="uri" xlink:href="https://spdbv.unil.ch/disclaim.html">https://spdbv.unil.ch/disclaim.html</ext-link>) the energy of the cleaned protein was minimized and optimized (<xref ref-type="bibr" rid="B24">Guex and Peitsch, 1997</xref>). The active site and binding pocket of the target protein SarA (PDB: 2fnp) was identified by CASTp online server (<xref ref-type="fig" rid="F3">Figure 3</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Binding pocket of SarA protein, identified by CASTp (<ext-link ext-link-type="uri" xlink:href="http://sts.bioe.uic.edu/castp/index.html?2fnp">http://sts.bioe.uic.edu/castp/index.html?2fnp</ext-link>) online server (<xref ref-type="bibr" rid="B59">Tian et al., 2018</xref>).</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g003.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>2.3 Molecular docking</title>
<p>The molecular docking between phytochemicals from <italic>S. album</italic> and SarA protein of <italic>S. aureus</italic> was carried out using PyRx software v0.8 (<ext-link ext-link-type="uri" xlink:href="https://sourceforge.net/projects/pyrx/">https://sourceforge.net/projects/pyrx/</ext-link>) which works based on the Auto Dock vina configuration (<xref ref-type="bibr" rid="B17">Dallakyan and Olson, 2015</xref>) and docking was performed based on the previous methods with small modification (<xref ref-type="bibr" rid="B44">Muhammad and Fatima, 2015</xref>; <xref ref-type="bibr" rid="B7">Bhowmik et al., 2021</xref>; <xref ref-type="bibr" rid="B19">Dey et al., 2023</xref>). The protein structure was converted into a macromolecule and the ligands were converted to PDBQT format. The center and grid box size of the docked complexes were set as for center X: 3.8347&#xa0;&#xc5;, Y: &#x2212;0.1554&#xa0;&#xc5;, Z: 8.7332&#xa0;&#xc5; and for dimension X: 48.7233&#xa0;&#xc5;, Y: 41.3090&#xa0;&#xc5;, Z: 59.7350&#xa0;&#xc5; respectively. The final docking calculation was conducted using PyRx and top molecules were selected based on lower binding energy. The binding interactions and poses were explored via Discovery Studio software.</p>
</sec>
<sec id="s2-4">
<title>2.4 Molecular dynamics</title>
<p>YASARA (Yet Another Scientific Artificial Reality Application) Dynamics software v19.12.4 was used to conduct molecular dynamic simulation with the help of the Assisted Model Building with Energy Refinement (AMBER)14 force field (<xref ref-type="sec" rid="s10">Supplementary Material S1</xref>) (<xref ref-type="bibr" rid="B66">Wang et al., 2004</xref>; <xref ref-type="bibr" rid="B39">Land and Humble, 2018</xref>). The hydrogen bond network was initially cleaned up and optimized together with the docked complexes. In order to reduce the protein complexes using a TIP3P water solvation model (0.997&#xa0;g/L1, 25 c, 1 atm), the steepest gradient approaches were used (<xref ref-type="bibr" rid="B27">Harrach and Drossel, 2014</xref>). The physiological conditions were set at 0.9% NaCl, 310K, and pH 7.4 (<xref ref-type="bibr" rid="B35">Krieger et al., 2012</xref>) to neutralize the simulated system. The simulation time step was set as normal at 2 &#xd7; 1.25 frames per second. The long-range electrostatic interaction was calculated by the particle mesh Ewald (PME) method with a cutoff radius of 8.0&#xa0;&#xc5; (<xref ref-type="bibr" rid="B22">Essmann et al., 1995</xref>). The simulation trajectories were saved after every 100 ps and the final simulation run was conducted for 100&#xa0;ns (<xref ref-type="bibr" rid="B36">Krieger and Vriend, 2015</xref>). The root-mean-square deviation, the solvent-accessible surface area, the radius of gyration, and hydrogen bonding were all assessed using the simulation trajectories (<xref ref-type="bibr" rid="B5">Baildya et al., 2021</xref>; <xref ref-type="bibr" rid="B30">Islam et al., 2021</xref>).</p>
</sec>
<sec id="s2-5">
<title>2.5 Binding-free energy calculation using MM/PBSA</title>
<p>Calculating the binding free energy is a crucial approach for evaluating the strength of the interaction between a drug and a protein. This analysis provides insights into the energetic aspects of the drug-protein complex. To determine the binding free energy, various snapshots of the complex were analyzed using the MM-Poisson&#x2013;Boltzmann surface area (MM-PBSA) method in YASARA software. The calculation involved the following formula:</p>
<p>MM/PBSA binding free energy &#x3d; EpotReceptor &#x2b; EsolvReceptor &#x2b; EpotLigand &#x2b; EsolvLigand&#x2212;EpotComplex&#x2212;EsolvComplex.</p>
<p>The calculations were performed using the AMBER 14 force field, and YASARA macros were utilized for efficient computation of the MM-PBSA binding energy.</p>
</sec>
<sec id="s2-6">
<title>2.6 Principal components analysis</title>
<p>Principal component analysis (PCA) was utilized to explore the overall variability among protein-ligand complexes, including comparisons with the apo form and a drug-protein complex, by considering all the structural features (<xref ref-type="bibr" rid="B2">Akash et al., 2023b</xref>; <xref ref-type="bibr" rid="B1">2023a</xref>). This method allows for the identification and categorization of structural changes in protein-ligand complexes that occur during the simulation by comparing different variables. Through diagonalization of the covariance matrices and solving the eigenvalue and eigenvector problems, PCA was performed on the complexes. The eigenvalues provided information about the magnitude and direction of structural fluctuations, while the eigenvectors represented the directions of these fluctuations. The MD trajectories spanning 100&#xa0;ns were pre-processed and standardized by scaling to unit variance and removing the mean (<xref ref-type="bibr" rid="B29">Ichiye and Karplus, 1991</xref>; <xref ref-type="bibr" rid="B53">Shukla and Tripathi, 2020</xref>). The PCA technique was implemented using Python v3.11 with the Scikit-learn v1.2 library, and the results were visualized using Matplotlib v3.7 (<xref ref-type="sec" rid="s10">Supplementary Material S2</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 ADMET analysis</title>
<p>The phytochemicals that passed the docking study were then subjected to absorption, distribution, metabolism, excretion, and toxicity (ADMET) analysis to see whether they have the necessary qualities to be considered as lead molecules. Therefore, the pkcsm (<xref ref-type="bibr" rid="B49">Pires et al., 2015</xref>) and SwissADME (<xref ref-type="bibr" rid="B16">Daina et al., 2017</xref>) web servers were used to analyze ADMET profiles and calculate molecules&#x2019; adherence to Lipinski&#x2019;s rule of five respectively.</p>
</sec>
<sec id="s2-8">
<title>2.8 Pharmacophore mapping</title>
<p>The pharmacophore mapping analysis of the top three ligands was performed using the online server PharmMapper (<xref ref-type="bibr" rid="B68">Wang et al., 2017</xref>). The ligands were obtained in sdf format from the PubChem server and then uploaded to the server. During the process, the &#x201c;maximum number of conformations&#x201d; parameter was set to 1,000. All available targets were selected in the &#x201c;select target set&#x201d; parameter, and the &#x201c;number of reserved matched targets&#x201d; parameter was set to 1,000. The fit score cut-off value in the advanced settings was set at 0. The default settings were used for all other parameters.</p>
</sec>
<sec id="s2-9">
<title>2.9 <italic>In vitro</italic> antibacterial activity</title>
<sec id="s2-9-1">
<title>2.9.1 Chemical and reagents</title>
<p>The compounds Vitexin (CID: 5280441), Isovitexin (CID: 162350), and Orientin (CID: 5281675) were purchased from Sigma-Aldrich as HPLC standards. Methanol, used for sample preparation, was of HPLC grade. The antibiotic drug ciprofloxacin was purchased from Square Pharmaceuticals Ltd. Luria Bertani (LB) broth and LB agar media were bought from Sigma-Aldrich (United States).</p>
</sec>
<sec id="s2-9-2">
<title>2.9.2 Collection of bacterial sample</title>
<p>Skin cancer associated bacteria <italic>S. aureus</italic> were collected from Professor Joardar DNA and Chromosome Research Laboratory, Department of Genetic Engineering and Biotechnology, University of Rajshahi, Bangladesh. Which was previously clinically isolated from skin cancer patient. After collection, the bacteria were cultured in LB agar meida and allow to grow it at 37&#xb0;C for overnight. For long-term storage <italic>S. aureus</italic> were kept at &#x2212;80&#xb0;C. <italic>S. aureus</italic> is classified as a Biosafety Level 2 (BSL-2) pathogen. Therefore, we follow all appropriate guidelines and regulations for the use and handling of this bacteria.</p>
</sec>
<sec id="s2-9-3">
<title>2.9.3 Determination of <italic>in vitro</italic> antibacterial activity</title>
<p>The three most promising compounds, Vitexin (CID: 5280441), Isovitexin (CID: 162350), and Orientin (CID: 5281675), which exhibited significant inhibitory effects against <italic>S. aureus</italic> associated with skin cancer through <italic>in silico</italic> analysis, were chosen for further evaluation of their <italic>in vitro</italic> antibacterial activity against this skin cancer-associated bacteria. To prepare the test solutions, all three compounds were dissolved in 60% methanol and diluted to a concentration of 50&#xa0;&#x3bc;g/mL. Subsequently, an <italic>in vitro</italic> antibacterial assessment was conducted using the disc diffusion method, with slight modifications (<xref ref-type="bibr" rid="B60">Tiruneh et al., 2022</xref>), at a concentration of 50&#xa0;&#xb5;g/disc. The bacterial cultures were initially grown overnight in nutrient broth at 37&#xb0;C, with agitation at 180&#xa0;rpm. Subsequently, an overnight bacterial suspension with a concentration of 1 &#xd7; 10<sup>6</sup>&#xa0;CFU/mL was evenly spread onto LB agar plates. Whatman No. 1 filter paper discs, each with a diameter of 5&#xa0;mm, were utilized in the experiment. These discs were impregnated with 50&#xa0;&#xb5;g of each compound (Vitexin, Isovitexin, and Orientin) and thoughtfully positioned on the agar plates. Ciprofloxacin, an antibiotic drug, was employed as a positive control. After 24&#xa0;h of incubation, the presence of clear zones around the discs indicated inhibition of bacterial growth. The diameters of these inhibition zones were measured using a millimeter (mm) scale. The experiment was repeated three times to ensure accuracy, and the data were subsequently presented as the mean and standard deviation of the results.</p>
</sec>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Molecular docking study</title>
<p>
<italic>S. aureus</italic> is associated with skin cancer by secreting virulence factors which are regulated by SarA protein (<xref ref-type="bibr" rid="B10">Bromfield et al., 2023</xref>). Interestingly, there was no published study has been reported on the inhibitory activity of <italic>S. album</italic> phytochemicals on SarA protein. Therefore, in this current investigation, we performed <italic>in silico</italic> docking study targeting SarA (PDB ID: 2fnp) protein of <italic>S. aureus</italic> which is responsible for the expression of many virulence genes (<xref ref-type="bibr" rid="B31">Jiang et al., 2023</xref>), by using <italic>S. album</italic> derived phytochemicals. The active site residue of SarA protein are A:Phe110, A:Ser114, A:Thr117, A: Thr118, A:Lys121, A:Glu223, A:Leu224, B:Thr141, B:Thr142, B:Glu145, B:Asn146, B:His159, and B:Tyr162 (<xref ref-type="table" rid="T1">Table 1</xref>). In our study, we found all three compounds strongly bind with the most of the active site residues of SarA protein including A:Phe110, A:Thr117, A:Lys121, A:Glu223, A:Leu224, B:Asn146, and B:His159 (<xref ref-type="table" rid="T2">Table 2</xref>), which indicates that these three compounds can potentially significant for the inhibition of the target protein SarA.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Active side residue of SarA protein identified by CASTp online server (<xref ref-type="bibr" rid="B59">Tian et al., 2018</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Target protein</th>
<th align="center">Active side residue</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">SarA (PDB: 2fnp)</td>
<td align="center">A:Phe110, A:Ser114, A:Thr117, A: Thr118, A:Lys121, A:Glu223, A:Leu224, B:Thr141, B:Thr142, B:Glu145, B:Asn146, B:His159, B:Tyr162</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Non-covalent interaction of the ligand molecules against SarA protein of <italic>Staphylococcus aureus</italic>, binding energy, non-covalent interaction, interacting amino acids, bond types and their distance.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Complex</th>
<th align="center">Binding energy (kcal/mole)</th>
<th align="center">Amino acid residues</th>
<th align="center">Bond types</th>
<th align="center">Distance &#xc5;)</th>
<th align="center">Angle (&#x2da;)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="center">2fnp &#x2b; CID:5280441</td>
<td rowspan="5" align="center">&#x2212;9.4</td>
<td align="center">B:Asn146</td>
<td align="center">H</td>
<td align="center">2.29</td>
<td align="center">126.198</td>
</tr>
<tr>
<td align="center">A:Leu224</td>
<td align="center">H</td>
<td align="center">2.16</td>
<td align="center">145.587</td>
</tr>
<tr>
<td align="center">A:Glu223</td>
<td align="center">H</td>
<td align="center">2.66</td>
<td align="center">93.504</td>
</tr>
<tr>
<td align="center">A:Lys121</td>
<td align="center">H</td>
<td align="center">2.73</td>
<td align="center">110.107</td>
</tr>
<tr>
<td align="center">B:His159</td>
<td align="center">H</td>
<td align="center">2.66</td>
<td align="center">127.773</td>
</tr>
<tr>
<td rowspan="6" align="center">2fnp &#x2b; CID:162350</td>
<td rowspan="6" align="center">&#x2212;9.0</td>
<td align="center">A:Glu221</td>
<td align="center">H</td>
<td align="center">2.06</td>
<td align="center">136.664</td>
</tr>
<tr>
<td align="center">A:Glu223</td>
<td align="center">H</td>
<td align="center">2.24</td>
<td align="center">161.549</td>
</tr>
<tr>
<td align="center">A:Lys121</td>
<td align="center">H</td>
<td align="center">2.77</td>
<td align="center">123.346</td>
</tr>
<tr>
<td align="center">B:His159</td>
<td align="center">H</td>
<td align="center">2.40</td>
<td align="center">134.646</td>
</tr>
<tr>
<td align="center">A:Phe110</td>
<td align="center">PP</td>
<td align="center">5.30</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center">B:Tyr142</td>
<td align="center">PP</td>
<td align="center">5.08</td>
<td align="center">-</td>
</tr>
<tr>
<td rowspan="4" align="center">2fnp &#x2b; CID:5281675</td>
<td rowspan="4" align="center">&#x2212;8.6</td>
<td align="center">B:Asn146</td>
<td align="center">H</td>
<td align="center">2.46</td>
<td align="center">127.061</td>
</tr>
<tr>
<td align="center">B:Asn158</td>
<td align="center">H</td>
<td align="center">2.18</td>
<td align="center">135.591</td>
</tr>
<tr>
<td align="center">A:Lys121</td>
<td align="center">H</td>
<td align="center">2.70</td>
<td align="center">107.513</td>
</tr>
<tr>
<td align="center">B:His159</td>
<td align="center">H</td>
<td align="center">2.07</td>
<td align="center">140.478</td>
</tr>
<tr>
<td rowspan="3" align="center">2fnp &#x2b; CID:114776</td>
<td rowspan="3" align="center">&#x2212;7.7</td>
<td align="center">A:Lys121</td>
<td align="center">H</td>
<td align="center">2.94</td>
<td align="center">122.446</td>
</tr>
<tr>
<td align="center">B:Asn146</td>
<td align="center">H</td>
<td align="center">2.41</td>
<td align="center">134.582</td>
</tr>
<tr>
<td align="center">B:His159</td>
<td align="center">H</td>
<td align="center">2.33</td>
<td align="center">131.92</td>
</tr>
<tr>
<td rowspan="3" align="center">2fnp &#x2b; CID:5281654</td>
<td rowspan="3" align="center">&#x2212;7.4</td>
<td align="center">A:Glu223</td>
<td align="center">H</td>
<td align="center">2.78</td>
<td align="center">102.168</td>
</tr>
<tr>
<td align="center">B:Asn146</td>
<td align="center">H</td>
<td align="center">2.17</td>
<td align="center">150.899</td>
</tr>
<tr>
<td align="center">B:His159</td>
<td align="center">H</td>
<td align="center">2.44</td>
<td align="center">138.895</td>
</tr>
<tr>
<td rowspan="4" align="center">2fnp &#x2b; CID:2764 (Control)</td>
<td rowspan="4" align="center">&#x2212;8.6</td>
<td align="center">A:Thr117</td>
<td align="center">H</td>
<td align="center">2.38</td>
<td align="center">107.41</td>
</tr>
<tr>
<td align="center">A:Asp120</td>
<td align="center">H</td>
<td align="center">3.28</td>
<td align="center">105.05</td>
</tr>
<tr>
<td align="center">B:Tyr162</td>
<td align="center">H</td>
<td align="center">5.22</td>
<td align="center">128.49</td>
</tr>
<tr>
<td align="center">B:Gln166</td>
<td align="center">H</td>
<td align="center">3.79</td>
<td align="center">160.366</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>H, Hydrogen bond; PP, Pi-pi sigma bond.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In a molecular docking study, from 50 compounds of <italic>S. album</italic> top five compounds were chosen based on the lowest binding energy, interaction with target protein, pose and RMSD value. Compound CID: 5280441 found a maximum binding energy &#x2212;9.4&#xa0;kcal/mol followed by CID: 162350 and CID: 5281675 with binding energy of &#x2212;9.0&#xa0;kcal/mol and &#x2212;8.6&#xa0;kcal/mol respectively compared to the positive control ciprofloxacin CID: 2764 with &#x2212;8.6&#xa0;kcal/mol (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
<p>Compared to the previous study our current compounds showed better binding affinity than compound hesperidin which interacts with active sites of SarA with the binding energy of &#x2212;6.9&#xa0;kcal/mol by revealing two hydrogen bonding interactions at Thr 117 and Lys 163 (<xref ref-type="bibr" rid="B61">Tong et al., 2015</xref>). Another study reported that benzimidazole type NHC precursors 1a-d molecules exhibited binding energy ranging from &#x2212;5.04 to &#x2212;5.46&#xa0;kcal/mol with the SarA protein which is comparatively lower to our current findings and did not show any kinds of hydrogen bond (<xref ref-type="bibr" rid="B64">&#xdc;st&#xfc;n et al., 2021</xref>), the difference of the binding energy maybe due to presence of more hydrogen bond interaction between the protein and our current ligands (<xref ref-type="fig" rid="F4">Figure 4</xref>). Some other studies also found that the SarA protein of <italic>S. aureus</italic> was inhibited by different compounds (<xref ref-type="bibr" rid="B18">de Oliveira et al., 2019</xref>; <xref ref-type="bibr" rid="B13">Cheruvanachari et al., 2023</xref>). However, in our study five hydrogen bonds were found from complex 2fnp &#x2b; CID: 5280441 at B: Asn146 (2.29&#xa0;&#xc5;), A:Leu224 (2.16&#xc5;), A:Glu223 (2.66&#xc5;), A:Lys121 (2.73&#xc5;) and B:His159 (2.66&#xa0;&#xc5;) (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Similarly, Complex 2fnp &#x2b; CID:162350 was stabilized by four hydrogen bonds at A:Glu221 (2.06&#xa0;&#xc5;), A:Glu223 (2.24&#xa0;&#xc5;), A:Lys121 (2.77&#xc5;) and B: His159 (2.40&#xa0;&#xc5;) (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Moreover, the interaction between 2fnp and compounds CID: 5281675 revealed four hydrogen bonds in A chain of 2fnp protein at A:Lys121 (2.70&#xa0;&#xc5;) and B chain of 2fnp protein at B: Asn146 (2.46&#xa0;&#xc5;), B: Asn158 (2.18&#xa0;&#xc5;) and B:His159 (2.07&#xa0;&#xc5;) (<xref ref-type="fig" rid="F4">Figure 4C</xref>). Additionally, the complexes 2fnp &#x2b; CID: 114776 and 2fnp &#x2b; CID: 5281654 showed almost similar binding energy with &#x2212;7.7 and &#x2212;7.4&#xa0;kcal/mol respectively (<xref ref-type="table" rid="T2">Table 2</xref>), and also interact target protein with three hydrogen bonds where two residue such as B:Asn146 and B:His159 were same with different distance (<xref ref-type="fig" rid="F4">Figures 4D, E</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Molecular docking interactions of the compounds from <italic>S. album</italic> and SarA protein of <italic>Staphylococcus aureus</italic>; 2d view of compounds CID: 5280441 <bold>(A)</bold>, CID: 162350 <bold>(B)</bold>, CID: 5281675 <bold>(C)</bold>, CID: 114776 <bold>(D)</bold>, CID: 5281654 <bold>(E)</bold> and CID: 2764 <bold>(F)</bold> respectively. Figures were generated by using Discovery Studio v21.1.0.0.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g004.tif"/>
</fig>
<p>In comparison with other three lead compounds, the positive control CID:2764 exhibited four hydrogen bond at A:Thr117 (2.38&#xa0;&#xc5;), A:Asp120 (3.28&#xa0;&#xc5;), B:Tyr162 (5.22&#xa0;&#xc5;), B:Gln166 (3.79&#xa0;&#xc5;). Overall, <italic>in silico</italic> docking study revealed that the three best compounds from <italic>S. album</italic> exhibited better inhibitory activity than positive control ciprofloxacin. This finding suggests that the binding interactions may serve as a potential mechanism accountable for the inhibition of <italic>S. aureus</italic> associated skin cancer.</p>
</sec>
<sec id="s3-2">
<title>3.2 Molecular dynamics</title>
<p>Molecular dynamics (MD) simulations are performed on protein-ligand complexes to gain a detailed understanding of their dynamic behavior at an atomic level (<xref ref-type="bibr" rid="B53">Shukla and Tripathi, 2020</xref>). Which, enables a dynamic view of their behavior, providing valuable information for drug discovery, understanding biological processes, and elucidating structure-function relationships (<xref ref-type="bibr" rid="B25">Guterres and Im, 2020</xref>). In this molecular dynamics simulation, the three best docked complexes was performed to validate the docking conformational stability and its rigidity at 100&#xa0;ns time-dependent manner which enables the uncovering of potent inhibitors. The root means square deviations (RMSD), solvent accessible surface area (SASA), the radius of gyration (Rg), and the hydrogen bonds of the SarA protein of Staphylococcus <italic>aureus</italic> and the best docked ligand complex are shown in <xref ref-type="fig" rid="F5">Figure 5</xref>.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>The molecular dynamics simulation study of SarA protein of <italic>Staphylococcus aureus</italic> and C1, C2 and C3 complexes compared to the apo protein and positive control (PC) ciprofloxacin; root mean square deviation <bold>(A)</bold>, radius of gyration <bold>(B)</bold>, solvent accessible surface area <bold>(C)</bold>, and hydrogen bond <bold>(D)</bold>.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g005.tif"/>
</fig>
<p>The Root Mean Square Deviation (RMSD) is a widely used metric for evaluating structural variations and determining the stability, precision, and conformational changes in protein-ligand complexes (<xref ref-type="bibr" rid="B55">Singh et al., 2023</xref>). In this study, we conducted an analysis of the RMSD values for the complex formed between drug candidate compounds and the SarA protein over a simulation period of 100&#xa0;ns. The average RMSD value for complexes C1, C2, C3, Apo and PC was 2.57&#xa0;&#xc5;, 2.07&#xa0;&#xc5;, 2.03&#xa0;&#xc5;, 2.10&#xa0;&#xc5;, and 1.18&#xa0;&#xc5; respectively (<xref ref-type="table" rid="T3">Table 3</xref>). According to the simulation result, the C1 complex showed the highest RMSD value between 20 and 40&#xa0;ns which was 2.5&#xa0;&#xc5; to 4.0&#xa0;&#xc5; and exhibited increased RMSD value after 20&#xa0;ns by following the upward movements. This might be due to the conformational variability of C1 complex after 20&#xa0;ns. On the other hand, other two complexes C2 and C3 maintained a stable RMSD value from the very beginning to the rest of the simulation period which was almost similar to the RMSD profile of Apo protein and positive control (PC) ciprofloxacin (<xref ref-type="fig" rid="F5">Figure 5A</xref>). The results of the analysis indicate that complexes C2 and C3 exhibited higher structural stability and maintained a consistent conformation throughout the simulation period in comparison to the C1 complex. The lower and more stable RMSD values observed for C2 and C3 suggest that they performed better in terms of overall structural integrity and robustness. Based on the RMSD findings, it can be concluded that C2 and C3 possess enhanced stability compared to the C1 complex.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The average values of MD parameters RMSD, Rg, SASA and RMSF for C1, C2, C3, and PC (Positive control, ciprofloxacin).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Parameters</th>
<th align="center">C1</th>
<th align="center">C2</th>
<th align="center">C3</th>
<th align="center">Apo</th>
<th align="center">PC</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">RMSD</td>
<td align="center">2.57</td>
<td align="center">2.07</td>
<td align="center">2.03</td>
<td align="center">2.10</td>
<td align="center">1.81</td>
</tr>
<tr>
<td align="center">Rg</td>
<td align="center">22.05</td>
<td align="center">22.43</td>
<td align="center">22.10</td>
<td align="center">22.38</td>
<td align="center">22.19</td>
</tr>
<tr>
<td align="center">SASA</td>
<td align="center">13826.88</td>
<td align="center">13824.28</td>
<td align="center">13832.02</td>
<td align="center">13810.52</td>
<td align="center">13712.75</td>
</tr>
<tr>
<td align="center">RMSF</td>
<td align="center">1.62</td>
<td align="center">1.42</td>
<td align="center">1.58</td>
<td align="center">1.76</td>
<td align="center">1.42</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The radius of gyration (Rg) is a crucial metric that provides insights into the overall size of a protein-ligand complex (<xref ref-type="bibr" rid="B43">Miraz et al., 2023</xref>). It is a fundamental measure used to assess the structural fluctuations occurring during molecular dynamics (MD) simulations. By analyzing Rg, we can quantitatively evaluate the degree to which the protein&#x2019;s structure changes the simulation (<xref ref-type="bibr" rid="B54">Singh et al., 2021</xref>). The average Rg values for each complexes ranging from 22.05 to 22.43 (<xref ref-type="table" rid="T3">Table 3</xref>). The Rg profile of the three complexes showed a similar trend with the Apo protein and positive control throughout the whole simulation period ranging from 21 to 23&#xa0;&#xc5; (<xref ref-type="fig" rid="F5">Figure 5B</xref>). A lower Rg value is commonly associated with a compact and rigid structure (<xref ref-type="bibr" rid="B30">Islam et al., 2021</xref>). This suggests that all complexes are positioned relatively closer to their center of mass, indicating a folded or globular conformation, and did not change throughout the 100&#xa0;ns simulation period.</p>
<p>The Solvent Accessible Surface Area (SASA) analysis is employed to determine the surface area of a molecule that is accessible to solvent molecules that is accessible to solvent molecules, can provide insights into the stability and folding of proteins (<xref ref-type="bibr" rid="B6">Baruah et al., 2022</xref>). The average SASA values for each complexes ranging from 13712.75 to 13832.02 (<xref ref-type="table" rid="T3">Table 3</xref>). In this study, the SASA profile of three complexes showed decreasing trend from the beginning of the simulation and after 20&#xa0;ns had a stable profile that was almost similar to the Apo protein and ciprofloxacin (PC) (<xref ref-type="fig" rid="F5">Figure 5C</xref>). It suggests that the complexes, Apo protein and ciprofloxacin share similar levels of accessibility to the surrounding solvent environment. This similarity in SASA values may imply similar levels of flexibility, exposure to functional sites, or potential for interactions. This implies that the ligand-binding regions in all complexes likely serve comparable roles or functions.</p>
<p>The analysis of hydrogen bonds in molecular dynamics (MD) simulations of protein-ligand complexes is crucial for understanding the nature and stability of their interactions (<xref ref-type="bibr" rid="B56">Takano et al., 2022</xref>). Hydrogen bonds play a vital role in determining the specificity and strength of binding between the protein and ligand (<xref ref-type="bibr" rid="B69">Wohlert et al., 2022</xref>). By monitoring hydrogen bond formation and breaking events during the simulation, one can gain insights into the dynamics of the complex, including transient interactions and the stability of the binding interface. The hydrogen bonds of C1, C2, and C3 complexes were similar to Apo protein and positive control (PC) ciprofloxacin, and did not change during the 100&#xa0;ns simulation period (<xref ref-type="fig" rid="F5">Figure 5D</xref>). These similar hydrogen bonds of all complexes suggest that the binding interactions between the protein and ligand are consistent and maintained throughout the simulation. It indicates that specific amino acid residues in the protein form stable hydrogen bonds with the ligand over time, contributing to the overall stability of the complex.</p>
<p>In our research, we also employed RMSF (Root Mean Square Fluctuation) analysis to investigate how individual atoms or residues in a biomolecular system behave in terms of flexibility and dynamics. This analysis also helped us pinpoint specific residues responsible for these fluctuations (<xref ref-type="bibr" rid="B2">Akash et al., 2023b</xref>). Accroding to the RMSF results, the average values ranging from 1.42 to 1.67&#xa0;&#xc5; which is outstanding results (<xref ref-type="table" rid="T3">Table 3</xref>). Among the top three compounds we studied, their RMSF profiles closely resembled that of the positive control, ciprofloxacin, as well as the Apo protein. However, we observed that certain residues exhibited significant fluctuations, exceeding 4&#xa0;&#xc5;, specifically residues numbered 85&#x2013;89 and 204&#x2013;210 (<xref ref-type="fig" rid="F6">Figure 6</xref>). Despite the overall similarity in the RMSF profiles of these compounds, some residues within the complexes displayed a higher degree of flexibility and mobility during our simulations. This increased flexibility in these particular residues may have important functional implications, such as aiding in binding events, accommodating structural changes, or playing a role in molecular recognition processes.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>The analysis of Root-mean-square fluctuation (RMSF) at 100&#xa0;ns molecular dynamics simulations periods.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g006.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 MMPBSA binding energy</title>
<p>The MMPBSA binding energy represents the net energy change associated with the formation of a protein-ligand complex compared to the unbound components. In our study, the binding free energy of protein-ligand interactions was determined using Molecular Mechanics/Poisson-Boltzmann Surface Area (MMPBSA) calculations. The MMPBSA binding free energies of all complexes were evaluated at a simulation period of 100&#xa0;ns, as depicted in <xref ref-type="fig" rid="F7">Figure 7</xref>. The average MMPBSA binding free energies for complexes C1, C2, C3 and PC were found to be &#x2212;309.08 &#xb1; 1.92, &#x2212;186.90 &#xb1; 2.40, &#x2212;292.07 &#xb1; 2.02, and &#x2212;215.193 &#xb1; 1.81&#xa0;kJ/mol, respectively, herein it has been shown that the MMPBSA binding energy for C1 and C2 were better that the positive control (<xref ref-type="table" rid="T4">Table 4</xref>). This negative MMPBSA binding energy indicates a favorable binding interaction, indicating that the binding of the ligand to the protein is energetically favorable and stable.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The MMPBSA binding free energy of C1, C2, C3, and PC complexes, where MMPBSA energy at 100&#xa0;ns simulation period <bold>(A)</bold> and average MMPBSA binding free energy <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g007.tif"/>
</fig>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>The average MMPBSA binding energy with other energies terms for each complexes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Parameter</th>
<th align="center">C1</th>
<th align="center">C2</th>
<th align="center">C3</th>
<th align="center">PC</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">EpotRecept&#x2b;</td>
<td align="center">&#x2212;7639.32821</td>
<td align="center">&#x2212;7429.266547</td>
<td align="center">&#x2212;6733.317016</td>
<td align="center">&#x2212;6716.32</td>
</tr>
<tr>
<td align="center">EsolvRecept&#x2b;</td>
<td align="center">&#x2212;32554.71565</td>
<td align="center">&#x2212;32994.28697</td>
<td align="center">&#x2212;33843.83064</td>
<td align="center">&#x2212;33813.8</td>
</tr>
<tr>
<td align="center">EpotLigand&#x2b;</td>
<td align="center">&#x2212;131.0693027</td>
<td align="center">&#x2212;131.5396274</td>
<td align="center">&#x2212;103.8731738</td>
<td align="center">&#x2212;98.8732</td>
</tr>
<tr>
<td align="center">EsolvLigand-</td>
<td align="center">&#x2212;480.7263047</td>
<td align="center">&#x2212;470.9471429</td>
<td align="center">&#x2212;562.047973</td>
<td align="center">&#x2212;532.048</td>
</tr>
<tr>
<td align="center">EpotComplex-</td>
<td align="center">&#x2212;8076.981531</td>
<td align="center">&#x2212;7718.179175</td>
<td align="center">&#x2212;7109.620093</td>
<td align="center">&#x2212;7119.62</td>
</tr>
<tr>
<td align="center">EsolvComplex</td>
<td align="center">&#x2212;32422.93294</td>
<td align="center">&#x2212;33120.60407</td>
<td align="center">&#x2212;33845.08681</td>
<td align="center">&#x2212;33825.1</td>
</tr>
<tr>
<td align="center">MMPBSA (mean &#xb1; SE)</td>
<td align="center">&#x2212;309.083 &#xb1; 1.92</td>
<td align="center">&#x2212;186.904 &#xb1; 2.40</td>
<td align="center">&#x2212;292.080 &#xb1; 2.02</td>
<td align="center">&#x2212;215.193 &#xb1; 1.81</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The inclusion of structural information, both in the docked and simulated states is shown in <xref ref-type="fig" rid="F8">Figure 8</xref>. The superimposition revelaed that all three lead compounds exhibited strong binding activity at the binding pocket whereas both docked and simulated complexes showed almost similar structure compared to the positive control.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>The superimposition of both docked (green colour) and simulated (at 100&#xa0;ns, violet colour) complexes. Where <bold>(A)</bold> C1, <bold>(B)</bold> C2 <bold>(C)</bold> C3, and <bold>(D)</bold> PC, and ligand defined as gray colour. Figures were generated by using Discovery Studio v21.1.0.0.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g008.tif"/>
</fig>
<p>The MD simulation snapshot of complexes C1, C2, C3 and PC at 0, 25, 50, 75, and 100&#xa0;ns are shown in <xref ref-type="fig" rid="F9">Figure 9</xref>. According to this results, both C1 nad C2 compounds remain sustain at the binding pocket of the target protein 2fnp throughout the simulation period where significant structural change were not observed for this both complexes (<xref ref-type="fig" rid="F9">Figure 9</xref>). Similarly, C3 compounds also almost suatain with the target protein however there was slight structural changes of the protein was observed particularly at 75, and 100&#xa0;ns. On the other hand, the positive control drug was splited out from the target protein at 50&#xa0;ns however at rest of the time control drug was bounded with target protein. Overall, superimposion results suggest that all three compounds were strongly bounded with the target protein throughout the simulation period compared to the positive control.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Snapshot of C1, C2, C3, and PC complexes at 0, 25, 50, 75, and 100&#xa0;ns simulation perioid. Figures were generated by using Discovery Studio v21.1.0.0.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g009.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Principle components analysis (PCA)</title>
<p>PCA is commonly used in MD simulations to analyze and understand the conformational dynamics and structural variations of apo form and protein-ligand complexes (<xref ref-type="bibr" rid="B48">Paris et al., 2014</xref>; <xref ref-type="bibr" rid="B70">Zarezade et al., 2018</xref>; <xref ref-type="bibr" rid="B34">Kitao, 2022</xref>). It was conducted to gain insights into the alterations in conformational dynamics that occur upon the binding of the ligand. PCA helps uncover the most significant structural changes and collective motions occurring in the protein-ligand complex during a molecular dynamics (MD) simulation (<xref ref-type="bibr" rid="B32">Kaur Bijral et al., 2022</xref>). In our study, PCA was utilized to explore the overall variability among protein-ligand complexes, including comparisons with the apo form. The techniques employed included the diagonalization of covariance matrices and mathematical eigenvalues, which provided information about the magnitude and direction of structural fluctuations. Furthermore, the eigenvectors represented the directions of these fluctuations (<xref ref-type="bibr" rid="B4">Alom et al., 2023</xref>).</p>
<p>
<xref ref-type="fig" rid="F10">Figure 10</xref> showcased PCA results derived from all the trajectories incorporating both coordinate information and pertinent structural features. The total explained variance ratio of Apo, C1, C2, and C3 was 35.89%, 39.51%, 38.74%, and 35.42% correspondingly. The conformational distributions of the apo form appear to be similar to those of the protein-ligand complexes. The results of the PCA analysis indicated that there is a widespread distribution of the apo form and protein-ligand complexes, suggesting that they exhibit conformational stability throughout the trajectory. Additionally, the distribution of the protein-ligand complexes closely resembled that of the Apo form, indicating a similarity in their overall structural characteristics. Moreover, the complexes did not display substantial structural variations throughout the MD simulation. The presence of low variance eigenvectors further confirmed the stability of the conformational states, suggesting that despite their dynamic nature, the complexes maintained consistent structural configurations.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Principal component analysis (PCA) was conducted to analyze the movements of the Apo form and protein-ligand complexes (C1, C2, and C3) over a 100&#xa0;ns molecular dynamics simulation. The PCA trajectories transitioned from cyan to purple as the simulation runtime progressed. The first and second principal components were plotted and the simulation time was presented as color map.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g010.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 ADMET analysis</title>
<p>ADMET (absorption, distribution, metabolism, excretion, and toxicity) analysis was performed for top three ligands to find out a lead compound. We found that CID: 5280441 (C1), CID: 162350 (C2) and CID: 5281675 (C3) followed Lipinski&#x2019;s rule although having few violations. The bioavailability score of C1, C2, and C3 compounds was 0.55, 0.55, and 0.17 respectively, which indicates that these compounds were physiologically active as the bioavailability score of a compound determines its physiological activity (<xref ref-type="bibr" rid="B28">Hosen et al., 2023</xref>). According to the solubility scale, insoluble &#x3c; &#x2212;10 &#x3c; poorly &#x3c; &#x2212;6 &#x3c; moderately &#x3c; &#x2212;4 &#x3c; soluble &#x3c; &#x2212;2 &#x3c; very &#x3c;0 &#x3c; highly water soluble (<xref ref-type="bibr" rid="B15">Daina et al., 2014</xref>), the water solubility of compounds C1 (&#x2212;2.845), C2 (&#x2212;2.812) and C3 (&#x2212;2.905) was found to be water-soluble. Compounds C2 showed the highest human intestinal absorption rate of 64.729% followed by C1 (46.695%) and C2 (43.733%). The Blood brain barrier and CNS permeability of all three compounds exhibited negative results (<xref ref-type="table" rid="T5">Table 5</xref>), indicaing that compounds are less likely to cross the BBB and less likely to permeate the central nervous system (CNS) as well (<xref ref-type="bibr" rid="B72">Shaker et al., 2023</xref>). Moreover, three screened compounds showed positive results in the human ether-a-go-go (hERG) l inhibitor test, and no toxicity was found in hepatotoxicity and AMES tests (<xref ref-type="table" rid="T5">Table 5</xref>). It suggests that these three compounds are suitable for further lab experiments. So, these compounds could be used as lead compounds to develop a drug against antibiotic resistant <italic>S. aureus</italic>.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Pharmacological and toxicity prediction of the screened compounds of <italic>S. album</italic> from SwissADME and PKCSM tools where every compound had almost favorable drug-likeness properties.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Parameter</th>
<th align="center">CID: 5280441</th>
<th align="center">CID: 162350</th>
<th align="center">CID: 5281675</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Molecular weight</td>
<td align="center">432.38</td>
<td align="center">432.38</td>
<td align="center">448.38</td>
</tr>
<tr>
<td align="left">Molecular formula</td>
<td align="center">C<sub>21</sub>H<sub>20</sub>O<sub>10</sub>
</td>
<td align="center">C<sub>21</sub>H<sub>20</sub>O<sub>10</sub>
</td>
<td align="center">C<sub>21</sub>H<sub>20</sub>O<sub>11</sub>
</td>
</tr>
<tr>
<td align="left">Hydrogen bond donor</td>
<td align="center">7</td>
<td align="center">7</td>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Hydrogen bond acceptor</td>
<td align="center">10</td>
<td align="center">10</td>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Rotatable bonds</td>
<td align="center">3</td>
<td align="center">3</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">LogP</td>
<td align="center">0.0917</td>
<td align="center">0.0917</td>
<td align="center">&#x2212;0.2027</td>
</tr>
<tr>
<td align="left">Surface Area</td>
<td align="center">173.994</td>
<td align="center">173.994</td>
<td align="center">178.788</td>
</tr>
<tr>
<td align="left">Bioavailability score</td>
<td align="center">0.55</td>
<td align="center">0.55</td>
<td align="center">0.17</td>
</tr>
<tr>
<td align="left">Water solubility</td>
<td align="center">&#x2212;2.845</td>
<td align="center">&#x2212;2.812</td>
<td align="center">&#x2212;2.905</td>
</tr>
<tr>
<td align="left">Human intestinal absorption</td>
<td align="center">46.695</td>
<td align="center">64.729</td>
<td align="center">43.733</td>
</tr>
<tr>
<td align="left">Blood brain barrier</td>
<td align="center">&#x2212;1.449</td>
<td align="center">&#x2212;1.375</td>
<td align="center">&#x2212;1.639</td>
</tr>
<tr>
<td align="left">CNS permeability</td>
<td align="center">&#x2212;3.834</td>
<td align="center">&#x2212;3.754</td>
<td align="center">&#x2212;4.018</td>
</tr>
<tr>
<td align="left">P-Glycoprotein 1 inhibitor</td>
<td align="center">No</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="left">CaCo2 Permeability</td>
<td align="center">&#x2212;0.956</td>
<td align="center">&#x2212;0.618</td>
<td align="center">&#x2212;1.25</td>
</tr>
<tr>
<td align="left">CYP2D6 substrate</td>
<td align="center">No</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="left">Oral Rat Acute Toxicity (LD50)</td>
<td align="center">2.595</td>
<td align="center">2.558</td>
<td align="center">2.572</td>
</tr>
<tr>
<td align="left">AMES Toxicity</td>
<td align="center">No</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="left">Hepatotoxicity</td>
<td align="center">No</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
<tr>
<td align="left">hERG 1 Inhibitor</td>
<td align="center">No</td>
<td align="center">No</td>
<td align="center">No</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-6">
<title>3.6 Pharmacophore mapping</title>
<p>In pharmacophore mapping, the fit score is a quantitative measure used to assess the degree of similarity or fit between a pharmacophore model and a given molecular structure or compound (<xref ref-type="bibr" rid="B47">Opo et al., 2022</xref>). Herein, we analyzed the pharmacophore mapping of all three compounds for SarA protein (<xref ref-type="fig" rid="F11">Figure 11</xref>), and the fit scores of compounds C1 and C3 are 4.51 and 3.701, respectively, which are higher than that of C2 with 2.95 (<xref ref-type="table" rid="T6">Table 6</xref>). These higher fit scores of the compounds indicate a closer match between the pharmacophore model and the compounds, suggesting a higher likelihood of the compounds exhibiting similar biological activity to the target or reference molecule. On the other hand, the normalized fit score provides a standardized measure of the similarity between a compound and a pharmacophore model, enabling comparisons across different models and compounds in pharmacophore mapping studies (<xref ref-type="bibr" rid="B58">Thangavel and Albratty, 2022</xref>; <xref ref-type="bibr" rid="B62">Tyagi et al., 2022</xref>).</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>Pharmacophore model of three best-docked compounds carried out by PharmMapper online server (<ext-link ext-link-type="uri" xlink:href="https://www.lilab-ecust.cn/pharmmapper/">https://www.lilab-ecust.cn/pharmmapper/</ext-link>).</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g011.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>The results of pharmacophore mapping analysis of three compounds for SarA protein.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Parameters</th>
<th align="center">CID: 5280441 (C1)</th>
<th align="center">CID: 162350 (C2)</th>
<th align="center">CID: 5281675 (C3)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Fit score</td>
<td align="center">4.51</td>
<td align="center">2.95</td>
<td align="center">3.701</td>
</tr>
<tr>
<td align="left">Normalized fit score</td>
<td align="center">0.7375</td>
<td align="center">0.6443</td>
<td align="center">0.7403</td>
</tr>
<tr>
<td align="left">Hydrophobic centre</td>
<td align="center">3</td>
<td align="center">2</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">Positively charged centre</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">Negatively charged centre</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">H bond donor</td>
<td align="center">1</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">H bond acceptor</td>
<td align="center">1</td>
<td align="center">2</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Aromatic ring</td>
<td align="center">0</td>
<td align="center">0</td>
<td align="center">0</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In our study, we revealed the highest normalized fit scores for compounds C1 and C3, with 0.7375 and 0.7403, respectively, followed by C2 with 0.6443 (<xref ref-type="table" rid="T6">Table 6</xref>). The normalized fit score of a compound is usually between 0 and 1, where 1 represents a perfect match between the compound and the pharmacophore model. This finding suggests that C2 and C3 were almost similar, and both compounds match the pharmacophore model well. Additionally, compounds C1 and C3 generated similar hydrophobic centers and one hydrogen bond acceptor each. On the other hand, C2 exhibited two hydrophobic centers with one hydrogen bond acceptor. Interestingly, except for C1, none of the other compounds exhibited a hydrogen bond donor. Moreover, all compounds C1, C2, and C3 did not generate any positively charged centers, negatively charged centers, or aromatic rings (<xref ref-type="table" rid="T6">Table 6</xref>).</p>
</sec>
<sec id="s3-7">
<title>3.7 <italic>In vitro</italic> antibacterial activity</title>
<p>To validate the findings of our <italic>in silico</italic> analysis, we conducted an <italic>in vitro</italic> assessment of the antibacterial activity of three key compounds, namely, Vitexin (CID:5280441), Isovitexin (CID:162350), and Orientin (CID:5281675) from <italic>S. album</italic> against <italic>S. aureus</italic> is shown in <xref ref-type="fig" rid="F12">Figure 12</xref>. The result revealed that all compounds exhibited almost similar level antibacterial activity. The compounds Vitexin showed the strong activity with zone of inhibition 19.8 &#xb1; 0.11&#xa0;mm followed by Isovitexin and Orientin with zone of inhibition 18.53 &#xb1; 0.27&#xa0;mm and 18.16 &#xb1; 0.08&#xa0;mm respectively compared to the positive control ciprofloxacin with 22.90 &#xb1; 0.05&#xa0;mm. On the other hand, negative solvent control doesnot effect on the growth of <italic>S. aureus</italic> (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). Hence, based on the comprehensive <italic>in vitro</italic> investigation, it can be inferred that these three compounds possess the potential to inhibit <italic>S. aureus</italic> associated with skin cancer. Nonetheless, further molecular studies are imperative to provide additional confirmation and insight into their mechanisms of action.</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption>
<p>Antibacterial activity of compounds Vitexin (CID:5280441), Isovitexin (CID:162350), and Orientin (CID:5281675) against skin cancer associated S. aureus at 50&#xa0;&#xb5;g/disc concentration. Where, <bold>(A)</bold> clear zone in disc diffusion method and <bold>(B)</bold> zone of inhibition. Ciprofloxacin (CIP) used as a positive control.</p>
</caption>
<graphic xlink:href="fchem-11-1273408-g012.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In this research, we find out the compounds CID: 5280441, CID: 162350 and CID: 5281675 from <italic>S. album</italic> showed strong inhibitory activity against the SarA protein of <italic>S. aureus</italic> through molecular docking study. This was further confirmed by molecular dynamic simulation and MMPBSA binding free energy at 100&#xa0;ns timeframe. Moreover, all of these compounds followed the drug candidate criteria through ADMET and pharmacophore model studies. <italic>In vitro</italic> antibacterial activity of this three lead compounds, namely, Vitexin, Isovitexin, and Orientin exhibited strong inhibitory activity of skin cancer associated <italic>S. aureus</italic>. Therefore, these three compounds could be used as promising compounds with antibacterial activity against for <italic>S. aureus</italic> associated skin cancer in humans. However, more experimental studies and modification of ligands with different functional groups need to be carried out for further confirmation and improvement of inhibitory activity.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>Data are available from the corresponding author upon reasonable request.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>Conceptualization, methodology, visualization and investigation: MEH; software and validation: MEH and MOF; formal analysis: MEH. SJS, and SA; resources: RZ and MOF; data curation: MEH, SJS, SA and MER; writing&#x2014;original draft preparation: MEH, SJS, SA, MM, UKA, and RZ; writing&#x2014;review and editing: MEH, SJS, MER, SA, MOF, MM, UKA, RZ, LO, ARZG, BS, and MB; supervision: RZ; project administration: RZ and HAN, ARZG, and MB. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work is financially supported by the Researchers Supporting Project number RSPD 2023R686, King Saud University, Riyadh, Saudi Arabia.</p>
</sec>
<ack>
<p>The authors extend their appreciation to the Researchers Supporting Project number RSPD 2023R686, King Saud University, Riyadh, Saudi Arabia.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2023.1273408/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2023.1273408/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akash</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abdelkrim</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bayil</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hosen</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Mukerjee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shater</surname>
<given-names>A. F.</given-names>
</name>
<etal/>
</person-group> (<year>2023a</year>). <article-title>Antimalarial drug discovery against malaria parasites through haplopine modification: an advanced computational approach</article-title>. <source>J. Cell. Mol. Med.</source> <volume>27</volume>, <fpage>3168</fpage>&#x2013;<lpage>3188</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.17940</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akash</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bay&#x131;l</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Hosen</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Mekonnen</surname>
<given-names>A. B.</given-names>
</name>
<etal/>
</person-group> (<year>2023b</year>). <article-title>Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives</article-title>. <source>Sci. Rep.</source> <volume>13</volume>, <fpage>16565</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-023-43175-x</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akbar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akbar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Santalum album L.(Santalaceae)</article-title>. <source>Handb. 200 Med. Plants A Compr. Rev. Their Tradit. Med. Uses Sci. Justifications</source> <volume>2</volume>, <fpage>1601</fpage>&#x2013;<lpage>1608</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-030-16807-0_165</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alom</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Bonna</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alom</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Faruqe</surname>
<given-names>M. O.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Unveiling neuroprotective potential of spice plant-derived compounds against alzheimer&#x2019;s disease: insights from computational studies</article-title>. <source>Int. J. Alzheimer&#x2019;s Dis.</source> <volume>2023</volume>, <fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1155/2023/8877757</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baildya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Dutta</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: an insight from molecular docking and MD-simulation studies</article-title>. <source>J. Mol. Struct.</source> <volume>1227</volume>, <fpage>129390</fpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2020.129390</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baruah</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kashyap</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guha</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Borgohain</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Insights into the interaction between polyphenols and &#x3b2;-lactoglobulin through molecular docking, MD simulation, and QM/MM approaches</article-title>. <source>ACS omega</source> <volume>7</volume>, <fpage>23083</fpage>&#x2013;<lpage>23095</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.2c00336</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhowmik</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nandi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis</article-title>. <source>Heliyon</source> <volume>7</volume>, <fpage>e06515</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06515</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blackman</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Broadbent</surname>
<given-names>E. K.</given-names>
</name>
<name>
<surname>Brade</surname>
<given-names>K. D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Updates on combination therapy for methicillin-resistant <italic>Staphylococcus aureus</italic> bacteremia</article-title>. <source>Curr. Infect. Dis. Rep.</source> <volume>22</volume>, <fpage>28</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/s11908-020-00737-8</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kumarasiri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Otero</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Suckow</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl) quinazolin-4 (3 H)-one</article-title>. <source>J. Am. Chem. Soc.</source> <volume>137</volume>, <fpage>1738</fpage>&#x2013;<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b00056</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromfield</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Hugenholtz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Frazer</surname>
<given-names>I. H.</given-names>
</name>
<name>
<surname>Khosrotehrani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Targeting <italic>Staphylococcus aureus</italic> dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: outlook for future therapies?</article-title> <source>Front. Oncol.</source> <volume>13</volume>, <fpage>1091379</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2023.1091379</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byrd Allyson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yasmine</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Segre Julia</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The human skin microbiome</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>16</volume>, <fpage>143</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2017.157</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakraborty</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The interplay among miRNAs, major cytokines, and cancer-related inflammation</article-title>. <source>Mol. Ther. Acids</source> <volume>20</volume>, <fpage>606</fpage>&#x2013;<lpage>620</lpage>. <pub-id pub-id-type="doi">10.1016/j.omtn.2020.04.002</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheruvanachari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pattnaik</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pragyandipta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pattnaik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Naik</surname>
<given-names>P. K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Deciphering the antibiofilm potential of 2-Phenylethyl methyl ether (PEME), a bioactive compound of Kewda essential oil against <italic>Staphylococcus aureus</italic>
</article-title>. <source>Microb. Pathog.</source> <volume>179</volume>, <fpage>106093</fpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2023.106093</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ci&#x105;&#x17c;y&#x144;ska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Olejniczak-Staruch</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sobolewska-Sztychny</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Narbutt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Skibi&#x144;ska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lesiak</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Ultraviolet radiation and chronic inflammation&#x2014;molecules and mechanisms involved in skin carcinogenesis: a narrative review</article-title>. <source>Life</source> <volume>11</volume>, <fpage>326</fpage>. <pub-id pub-id-type="doi">10.3390/life11040326</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Michielin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zoete</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>iLOGP: a simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach</article-title>. <source>J. Chem. Inf. Model.</source> <volume>54</volume>, <fpage>3284</fpage>&#x2013;<lpage>3301</lpage>. <pub-id pub-id-type="doi">10.1021/ci500467k</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Michielin</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Zoete</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>42717</fpage>&#x2013;<lpage>42813</lpage>. <pub-id pub-id-type="doi">10.1038/srep42717</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dallakyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2015</year>). &#x201c;<article-title>Small-molecule library screening by docking with PyRx</article-title>,&#x201d; in <source>Chemical biology</source> (<publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>243</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-2269-7_19</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Oliveira</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>da Cruz</surname>
<given-names>J. N.</given-names>
</name>
<name>
<surname>Mitre</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>da Costa</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Kataoka</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>da</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Antimicrobial, cytotoxic activity of the Syzygium aromaticum essential oil, molecular docking and dynamics molecular studies of its major chemical constituent</article-title>. <source>J. Comput. Theor. Nanosci.</source> <volume>16</volume>, <fpage>355</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1166/jctn.2019.8108</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Ema</surname>
<given-names>T. I.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: <italic>in silico</italic> admet profiling, molecular docking, molecular dynamics simulation, network pharmacology</article-title>. <source>Mol. Divers.</source> <volume>27</volume>, <fpage>857</fpage>&#x2013;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-022-10459-9</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#xed;az</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Alberto</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Vega-Hissi</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Gonz&#xe1;lez</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Arena</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Interference in <italic>Staphylococcus aureus</italic> biofilm and virulence factors production by human probiotic bacteria with antimutagenic activity</article-title>. <source>Arab. J. Sci. Eng.</source> <volume>47</volume>, <fpage>241</fpage>&#x2013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1007/s13369-021-05934-8</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Ganiny</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Gad</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>El-Sayed</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Shaldam</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Abbas</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The promising anti-virulence activity of candesartan, domperidone, and miconazole on <italic>Staphylococcus aureus</italic>
</article-title>. <source>Braz. J. Microbiol.</source> <volume>53</volume>, <fpage>1</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/s42770-021-00655-4</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Berkowitz</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Darden</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>L. G.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>A smooth particle mesh Ewald method</article-title>. <source>J. Chem. Phys.</source> <volume>103</volume>, <fpage>8577</fpage>&#x2013;<lpage>8593</lpage>. <pub-id pub-id-type="doi">10.1063/1.470117</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghildiyal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gabrani</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phytochemicals as antiviral agents: recent updates</article-title>. <source>Plant-derived Bioact. Prod. Prop. Ther. Appl.</source> <volume>12</volume>, <fpage>279</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-15-1761-7_12</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guex</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Peitsch</surname>
<given-names>M. C.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>SWISS&#x2010;MODEL and the Swiss&#x2010;Pdb Viewer: an environment for comparative protein modeling</article-title>. <source>Electrophoresis</source> <volume>18</volume>, <fpage>2714</fpage>&#x2013;<lpage>2723</lpage>. <pub-id pub-id-type="doi">10.1002/elps.1150181505</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guterres</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Improving protein-ligand docking results with high-throughput molecular dynamics simulations</article-title>. <source>J. Chem. Inf. Model.</source> <volume>60</volume>, <fpage>2189</fpage>&#x2013;<lpage>2198</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.0c00057</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanwell</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Lonie</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Vandermeerschd</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zurek</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hutchison</surname>
<given-names>G. R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Avogadro: an advanced semantic chemical editor, visualization, and analysis platform</article-title>. <source>J. Cheminform.</source> <volume>4</volume>, <fpage>17</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-4-17</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrach</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Drossel</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity</article-title>. <source>J. Chem. Phys.</source> <volume>140</volume>, <fpage>174501</fpage>. <pub-id pub-id-type="doi">10.1063/1.4872239</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hosen</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Faruqe</surname>
<given-names>M. O.</given-names>
</name>
<name>
<surname>Khalekuzzaman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Acharjee</surname>
<given-names>U. K.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Molecular docking and dynamics simulation approach of Camellia sinensis leaf extract derived compounds as potential cholinesterase inhibitors</article-title>. <source>Silico Pharmacol.</source> <volume>11</volume>, <fpage>14</fpage>. <pub-id pub-id-type="doi">10.1007/s40203-023-00151-7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichiye</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Karplus</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations</article-title>. <source>Proteins Struct. Funct. Bioinforma.</source> <volume>11</volume>, <fpage>205</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1002/prot.340110305</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islam</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Parves</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Mamun</surname>
<given-names>A. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>39</volume>, <fpage>3213</fpage>&#x2013;<lpage>3224</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2020.1761883</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Phage transcription activator RinA regulates <italic>Staphylococcus aureus</italic> virulence by governing sarA expression</article-title>. <source>Genes. Genomics</source> <volume>45</volume>, <fpage>191</fpage>&#x2013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1007/s13258-022-01352-8</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaur Bijral</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Manhas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Discovery of EGFR kinase&#x2019;s T790M variant inhibitors through molecular dynamics simulations, PCA-based dimension reduction, and hierarchical clustering</article-title>. <source>Struct. Chem.</source> <volume>33</volume>, <fpage>1957</fpage>&#x2013;<lpage>1964</lpage>. <pub-id pub-id-type="doi">10.1007/s11224-022-01967-3</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gindulyte</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PubChem in 2021: new data content and improved web interfaces</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume>, <fpage>D1388</fpage>&#x2013;<lpage>D1395</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa971</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitao</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Principal component analysis and related methods for investigating the dynamics of biological macromolecules</article-title>. <source>J</source> <volume>5</volume>, <fpage>298</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.3390/j5020021</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Krieger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dunbrack</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Hooft</surname>
<given-names>R. W. W.</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2012</year>). &#x201c;<article-title>Assignment of protonation states in proteins and ligands: combining pK a prediction with hydrogen bonding network optimization</article-title>,&#x201d; in <source>Computational drug discovery and design</source> (<publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>405</fpage>&#x2013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-465-0_25</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krieger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vriend</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>New ways to boost molecular dynamics simulations</article-title>. <source>J. Comput. Chem.</source> <volume>36</volume>, <fpage>996</fpage>&#x2013;<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.23899</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krueger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohamed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kolka</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Stoll</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zaugg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Linedale</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Skin cancer-associated <italic>S. aureus</italic> Strains can induce DNA damage in human keratinocytes by downregulating DNA repair and promoting oxidative stress</article-title>. <source>Cancers (Basel).</source> <volume>14</volume>, <fpage>2143</fpage>. <pub-id pub-id-type="doi">10.3390/cancers14092143</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krueger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zaugg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chisholm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Linedale</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lachner</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Teoh</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Secreted toxins from <italic>Staphylococcus aureus</italic> strains isolated from keratinocyte skin cancers mediate pro-tumorigenic inflammatory responses in the skin</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <fpage>789042</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2021.789042</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Land</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Humble</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2018</year>). &#x201c;<article-title>YASARA: a tool to obtain structural guidance in biocatalytic investigations</article-title>,&#x201d; in <source>Protein engineering</source> (<publisher-loc>New York</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>43</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7366-8_4</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Mazhar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Immune and inflammatory reponses to <italic>Staphylococcus aureus</italic> skin infections</article-title>. <source>Curr. Dermatol. Rep.</source> <volume>7</volume>, <fpage>338</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1007/s13671-018-0235-8</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q. M.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>W. X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). &#x201c;<article-title>Pyrolysis-GC/MS analysis of biomedical components of the pyrolyzate of Santalum album leaf treated by benzene/ethanol extraction</article-title>,&#x201d; in <conf-name>2008 2nd International Conference on Bioinformatics and Biomedical Engineering</conf-name>, <conf-loc>Shanghai, China</conf-loc>, <conf-date>16-18 May 2008</conf-date> (<publisher-name>IEEE</publisher-name>), <fpage>1213</fpage>&#x2013;<lpage>1216</lpage>.</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madhusudhan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pausan</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Halwachs</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Durdevi&#x107;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Windisch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kehrmann</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Molecular profiling of keratinocyte skin tumors links <italic>Staphylococcus aureus</italic> overabundance and increased human &#x3b2;-defensin-2 expression to growth promotion of squamous cell carcinoma</article-title>. <source>Cancers (Basel).</source> <volume>12</volume>, <fpage>541</fpage>. <pub-id pub-id-type="doi">10.3390/cancers12030541</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miraz</surname>
<given-names>M. M. H.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Nayem</surname>
<given-names>A.Al</given-names>
</name>
<name>
<surname>Chakrobortty</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Deb</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laskar</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Nigelladine a among selected compounds from nigella sativa exhibits propitious interaction with omicron variant of SARS-CoV-2: an <italic>in silico</italic> study</article-title>. <source>Int. J. Clin. Pract.</source> <volume>2023</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1155/2023/9917306</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhammad</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Fatima</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>
<italic>In silico</italic> analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides</article-title>. <source>Pharmacogn. Mag.</source> <volume>11</volume>, <fpage>S123</fpage>&#x2013;<lpage>S126</lpage>. <pub-id pub-id-type="doi">10.4103/0973-1296.157712</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okunade</surname>
<given-names>K. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Human papillomavirus and cervical cancer</article-title>. <source>J. Obstet. Gynaecol. (Lahore).</source> <volume>40</volume>, <fpage>602</fpage>&#x2013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1080/01443615.2019.1634030</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Viegas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>MRSA colonization in workers from different occupational environments&#x2014;a one health approach perspective</article-title>. <source>Atmos. (Basel)</source> <volume>13</volume>, <fpage>658</fpage>. <pub-id pub-id-type="doi">10.3390/atmos13050658</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Opo</surname>
<given-names>F. A. D. M.</given-names>
</name>
<name>
<surname>Alkarim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alrefaei</surname>
<given-names>G. I.</given-names>
</name>
<name>
<surname>Molla</surname>
<given-names>M. H. R.</given-names>
</name>
<name>
<surname>Alsubhi</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Alzahrani</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Pharmacophore-model-based virtual-screening approaches identified novel natural molecular candidates for treating human neuroblastoma</article-title>. <source>Curr. Issues Mol. Biol.</source> <volume>44</volume>, <fpage>4838</fpage>&#x2013;<lpage>4858</lpage>. <pub-id pub-id-type="doi">10.3390/cimb44100329</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paris</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ramseyer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Enescu</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A principal component analysis of the dynamics of subdomains and binding sites in human serum albumin</article-title>. <source>Biopolymers</source> <volume>101</volume>, <fpage>561</fpage>&#x2013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1002/bip.22418</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>D. E. V.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures</article-title>. <source>J. Med. Chem.</source> <volume>58</volume>, <fpage>4066</fpage>&#x2013;<lpage>4072</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00104</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Pullaiah</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ramulu</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Murthy</surname>
<given-names>K. S. R.</given-names>
</name>
<name>
<surname>Reddy</surname>
<given-names>V. D.</given-names>
</name>
<name>
<surname>Saradamma</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Swamy</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2021</year>). &#x201c;<article-title>Phytochemistry and pharmacological properties of Santalum album L</article-title>,&#x201d; in <source>Sandalwood: silviculture, conservation and applications</source> (<publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>67</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-16-0780-6_5</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reimche</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Chivukula</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Schmerer</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Pham</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Schlanger</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Genomic analysis of the predominant strains and antimicrobial resistance determinants within 1479 Neisseria gonorrhoeae isolates from the US Gonococcal Isolate Surveillance Project in 2018</article-title>. <source>Sex. Transm. Dis.</source> <volume>48</volume>, <fpage>S78</fpage>&#x2013;<lpage>S87</lpage>. <pub-id pub-id-type="doi">10.1097/olq.0000000000001471</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaker</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A machine learning-based quantitative model (LogBB_Pred) to predict the blood&#x2013;brain barrier permeability (logBB value) of drug compounds</article-title>. <source>Bioinformatics</source> <volume>39</volume> (<issue>10</issue>), <fpage>btad577</fpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btad577</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shariati</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dadashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moghadam</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>van Belkum</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yaslianifard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Darban-Sarokhalil</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate <italic>Staphylococcus aureus</italic> clinical isolates: a systematic review and meta-analysis</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <fpage>12689</fpage>&#x2013;<lpage>12716</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-69058-z</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Molecular dynamics simulation of protein and protein&#x2013;ligand complexes</article-title>. <source>Comput. drug Des.</source> <volume>2020</volume>, <fpage>133</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1007/978-981-15-6815-2_7</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Kushwaha</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Prajapati</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Shuaib</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Identification of FDA approved drugs and nucleoside analogues as potential SARS-CoV-2 A1pp domain inhibitor: an <italic>in silico</italic> study</article-title>. <source>Comput. Biol. Med.</source> <volume>130</volume>, <fpage>104185</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2020.104185</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Raja</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Medhi</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Gmx_qk: an automated protein/protein&#x2013;ligand complex simulation workflow bridged to MM/PBSA, based on gromacs and zenity-dependent GUI for beginners in MD simulation study</article-title>. <source>J. Chem. Inf. Model.</source> <volume>63</volume>, <fpage>2603</fpage>&#x2013;<lpage>2608</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.3c00341</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H. X.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Quantum chemical studies on hydrogen bonds in helical secondary structures</article-title>. <source>Biophys. Rev.</source> <volume>14</volume>, <fpage>1369</fpage>&#x2013;<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1007/s12551-022-01034-5</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Unakal</surname>
<given-names>C. G.</given-names>
</name>
</person-group> (<year>2022</year>). &#x201c;<article-title>
<italic>Staphylococcus aureus</italic>
</article-title>,&#x201d; in <source>StatPearls</source> (<publisher-loc>Treasure Island, FL</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>).</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thangavel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Albratty</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors</article-title>. <source>Arab. J. Chem.</source> <volume>15</volume>, <fpage>104334</fpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2022.104334</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tian</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>CASTp 3.0: computed atlas of surface topography of proteins</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>W363</fpage>&#x2013;<lpage>W367</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky473</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiruneh</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Tiruneh</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Abebe</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Ayele</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Phytochemical investigation and determination of antibacterial activity of solvent leave extracts of carissa spinarum</article-title>. <source>Infect. Drug Resist.</source> <volume>15</volume>, <fpage>807</fpage>&#x2013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.2147/idr.s352049</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tong</surname>
<given-names>S. Y. C.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Eichenberger</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Fowler</surname>
<given-names>V. G.</given-names>
<suffix>Jr</suffix>
</name>
</person-group> (<year>2015</year>). <article-title>
<italic>Staphylococcus aureus</italic> infections: epidemiology, pathophysiology, clinical manifestations, and management</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>28</volume>, <fpage>603</fpage>&#x2013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00134-14</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Tyagi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>M. K.</given-names>
</name>
</person-group> (<year>2022</year>). &#x201c;<article-title>Pharmacophore modeling and its applications</article-title>,&#x201d; in <source>Bioinformatics</source> (<publisher-name>Elsevier</publisher-name>), <fpage>269</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-323-89775-4.00009-2</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umdale</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahire</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aiwale</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jadhav</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mundada</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phytochemical investigation and antioxidant efficacy of wild, underutilized berries of economically important Indian Sandalwood (Santalum album L.)</article-title>. <source>Biocatal. Agric. Biotechnol.</source> <volume>27</volume>, <fpage>101705</fpage>. <pub-id pub-id-type="doi">10.1016/j.bcab.2020.101705</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xdc;st&#xfc;n</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>&#x15e;ahin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>&#xc7;elik</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tutar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>&#xd6;zdemir</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>G&#xfc;rb&#xfc;z</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Synthesis, characterization, antimicrobial and antibiofilm activity, and molecular docking analysis of NHC precursors and their Ag-NHC complexes</article-title>. <source>Dalt. Trans.</source> <volume>50</volume>, <fpage>15400</fpage>&#x2013;<lpage>15412</lpage>. <pub-id pub-id-type="doi">10.1039/d1dt02003j</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Hypericin enhances &#x3b2;-lactam antibiotics activity by inhibiting sarA expression in methicillin-resistant <italic>Staphylococcus aureus</italic>
</article-title>. <source>Acta Pharm. Sin. B</source> <volume>9</volume>, <fpage>1174</fpage>&#x2013;<lpage>1182</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2019.05.002</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Caldwell</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Kollman</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Case</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Development and testing of a general amber force field</article-title>. <source>J. Comput. Chem.</source> <volume>25</volume>, <fpage>1157</fpage>&#x2013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Buist</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>van Dijl</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>Staphylococcus aureus</italic> cell wall maintenance&#x2013;the multifaceted roles of peptidoglycan hydrolases in bacterial growth, fitness, and virulence</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>46</volume>, <fpage>fuac025</fpage>. <pub-id pub-id-type="doi">10.1093/femsre/fuac025</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>W356</fpage>&#x2013;<lpage>W360</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx374</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wohlert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Benselfelt</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>W&#xe5;gberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fur&#xf3;</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Berglund</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Wohlert</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Cellulose and the role of hydrogen bonds: not in charge of everything</article-title>. <source>Cellulose</source> <volume>1</volume>, <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1007/s10570-021-04325-4</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zarezade</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Abolghasemi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rahim</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Veisi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Behbahani</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>
<italic>In silico</italic> assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment</article-title>. <source>J. Mol. Model.</source> <volume>24</volume>, <fpage>337</fpage>&#x2013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1007/s00894-018-3858-6</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Badami</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Skin cancer diagnosis based on optimized convolutional neural network</article-title>. <source>Artif. Intell. Med.</source> <volume>102</volume>, <fpage>101756</fpage>. <pub-id pub-id-type="doi">10.1016/j.artmed.2019.101756</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>